HomeFUNDING
FUNDING
Medical device and diagnostics companies are always looking for ways to improve their products and services. In the ever-changing landscape of the healthcare industry, it’s essential for these companies to stay ahead of the curve. That’s why funding is always news.
Series A, B, and other rounds of funding are essential for medical device and diagnostics companies. They provide the necessary capital to help these businesses grow and innovate. And with so many investors interested in this space, there are plenty of opportunities for companies to secure the funding they need.
Aethlon Medical Announces Collaboration with University of Pittsburgh on NIH Grant for Head and Neck Cancer
The grant, entitled "Depleting exosomes to improve responses to immune therapy in head and neck squamous cell carcinoma" will profile the biomarkers of exosomes in patients with recurrent and metastatic head and neck cancer and will explore the impact of clinical depletion of exosomes using Aethlon's proprietary Hemopurifier device.
CardioMech AS Secures $18.5M Series A for its Transcatheter Mitral Valve Repair Technology
CardioMech AS is developing a catheter-based mitral valve repair technology as an alternative to open-heart cardiac surgery by placing its artificial chord(s) in the heart via a catheter to reduce or eliminate mitral regurgitation without opening the chest, stopping the heart, or going on heart-lung bypass.
CAPS Medical, MEDX Xelerator’s Portfolio Company, Raises $3.5 Million Series A
“CAPS was one of the first companies to join the incubator. CAPS CEO Ilan Uchitel has led his team, with the support of the incubator and its partners, to achieve all of its milestones, far ahead of schedule,” said Shai Policker, CEO of MEDX Xelerator and a CAPS Medical board member.
CytoSorbents Awarded $4.4 Million Contract by the U.S. Department of Defense
CytoSorbents reports the HemoDefend-BGA filter is designed to enable "universal plasma", or plasma that can be administered to anyone regardless of blood type, and to improve the safety of whole blood transfusions, by the rapid and efficient removal of anti-A and anti-B antibodies from these two blood products.
NeuroOne Medical Technologies Corporation Reduces Debt by $3.3 Million and Strengthens Balance Sheet
“Now that we have shored up our balance sheet, we are well-positioned to prepare for commercialization of our EVO Cortical Electrode product line with Zimmer Biomet, our strategic commercialization partner, accelerate additional research and development efforts, and explore uplisting to a national securities exchange,” says Dave Rosa, president and CEO, NeuroOne.
Nanox Imaging Announcement: Secures over $100M in Crossover Equity Investments
The funds raised are planned to primarily support the rollout of the Nanox.ARC deployments worldwide.
Curadigm Announces 1 Million € Funding From BPI France’s Deep Tech Program to Support Development of the Nanoprimer Platform
Curadigm notes the funding award highlights the Nanoprimer’s unique, groundbreaking approach to increasing therapeutic bioavailability and efficacy, which is applicable across multiple drug classes.
KAHTNU Surgical Receives $2M Funding: To Expand Worldwide Sales
The investment will help the company aggressively expand worldwide sales and marketing efforts as well as broaden and accelerate product development for spine and orthopedic surgeons.
Noteworth Secures $5 Million in Funding
With this new investment, Notework will continue to build upon the delivery of its first-of-its-kind Digital Healthcare platform.